MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Xenetic Biosciences Cash and Cash Equivalents 2011-2026 | XBIO
Annual Cash and Cash Equivalents Xenetic Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.88 M | 6.17 M | 8.98 M | 13.1 M | 18.2 M | 11.5 M | 10.4 M | 572 K | 5.53 M | 4.05 M | 132 K | 2.51 M | 4.84 M | 11.1 M | 17.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.2 M | 132 K | 8.14 M |
Quarterly Cash and Cash Equivalents Xenetic Biosciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.35 M | 4.12 M | 4.78 M | 5.16 M | 6.17 M | 6.84 M | 7.3 M | 7.82 M | 8.98 M | 9.78 M | 10.7 M | 12 M | 13.1 M | 13.8 M | 14.9 M | 16.2 M | 18.2 M | 19.7 M | 9.28 M | 10 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 572 K | 572 K | 572 K | 572 K | 5.53 M | 5.53 M | 5.53 M | 5.53 M | 4.05 M | 4.05 M | 4.05 M | 4.05 M | 132 K | 132 K | 132 K | 132 K | 2.51 M | 2.51 M | 2.51 M | 2.51 M | 4.84 M | 4.84 M | 4.84 M | 4.84 M | 11.1 M | 32 K | 32 K | 32 K | 17.1 M | 10 K | 10 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.7 M | 10 K | 6.66 M |
Cash and Cash Equivalents of other stocks in the Biotechnology industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
1.91 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
158 M | - | 2.43 % | $ 254 M |  Germany |
 |
Coherus BioSciences
CHRS
|
88.9 M | $ 1.76 | 2.92 % | $ 206 M |  USA |
 |
Happiness Biotech Group Limited
HAPP
|
261 K | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
3.06 M | - | -10.17 % | $ 12.2 K | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
231 M | $ 8.33 | 0.97 % | $ 228 M |  Israel |
 |
I-Mab
IMAB
|
4.76 B | - | - | $ 866 M | China |
 |
Midatech Pharma plc
MTP
|
8.53 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Biophytis SA
BPTS
|
5.57 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
81.8 M | - | 2.54 % | $ 160 B | France |
 |
Enlivex Therapeutics Ltd.
ENLV
|
5.67 M | $ 0.75 | 0.09 % | $ 34.3 M | Israel |
 |
Athira Pharma
ATHA
|
69.3 M | - | - | $ 269 M | USA |
 |
Esperion Therapeutics
ESPR
|
168 M | $ 3.13 | - | $ 651 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
54 M | - | 0.74 % | $ 768 M | Israel |
 |
Exelixis
EXEL
|
482 M | $ 50.34 | 1.78 % | $ 13.7 B | USA |
 |
Fortress Biotech
FBIO
|
79.4 M | $ 2.21 | -2.43 % | $ 61.7 M | USA |
|
Forte Biosciences
FBRX
|
77 M | $ 24.37 | 0.33 % | $ 316 M | USA |
 |
AbCellera Biologics
ABCL
|
129 M | $ 4.78 | -3.43 % | $ 1.43 B | Canada |
 |
Amphastar Pharmaceuticals
AMPH
|
170 M | $ 18.35 | 4.83 % | $ 858 M | USA |
 |
BioNTech SE
BNTX
|
7.68 B | $ 92.68 | -1.05 % | $ 22.4 B | Germany |
 |
Compugen Ltd.
CGEN
|
7.8 M | $ 2.82 | -0.39 % | $ 263 M | Israel |
 |
Checkmate Pharmaceuticals
CMPI
|
50.7 M | - | - | $ 231 M | USA |
 |
Genmab A/S
GMAB
|
3.55 B | $ 26.55 | -1.99 % | $ 1.72 B |  Danmark |
 |
Grifols, S.A.
GRFS
|
980 M | $ 7.7 | 1.84 % | $ 5.23 B |  Spain |
 |
Advaxis
ADXS
|
4.88 M | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
8.27 M | $ 3.53 | 4.13 % | $ 5.81 M | Israel |
 |
Aeterna Zentaris
AEZS
|
7.31 M | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
85.7 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
811 M | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
46.4 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
34 M | - | 1.93 % | $ 17.4 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
36.8 M | $ 6.88 | -2.13 % | $ 197 M | USA |
 |
Akero Therapeutics
AKRO
|
340 M | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
935 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
56.2 M | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
122 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
248 M | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
98.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
66.4 M | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
42.9 M | $ 21.77 | 5.22 % | $ 2.77 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
30 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
4.09 M | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
61.1 M | - | - | $ 10.1 M | USA |
 |
Galectin Therapeutics
GALT
|
17.7 M | $ 2.27 | 0.89 % | $ 145 M | USA |
 |
Alpine Immune Sciences
ALPN
|
13.4 M | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
3.22 M | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
49.9 M | - | - | $ 8.42 M | USA |